CSIMarket
 
Conocophillips  (COP)
Other Ticker:  
 
 
Price: $58.7800 $0.44 0.754%
Day's High: $59.93 Week Perf: 12.43 %
Day's Low: $ 58.36 30 Day Perf: 33.56 %
Volume (M): 1,868 52 Wk High: $ 59.93
Volume (M$): $ 109,051 52 Wk Avg: $39.26
Open: $58.77 52 Wk Low: $20.84



 Market Capitalization (Millions $) 126,788
 Shares Outstanding (Millions) 2,157
 Employees 10,400
 Revenues (TTM) (Millions $) 19,256
 Net Income (TTM) (Millions $) -2,655
 Cash Flow (TTM) (Millions $) -2,047
 Capital Exp. (TTM) (Millions $) 4,715

Conocophillips
ConocoPhillips is a major, integrated, global energy company. ConocoPhillips was incorporated in the state of Delaware on November 16, 2001, in connection with, and in anticipation of, the merger between Conoco Inc. (Conoco) and Phillips Petroleum Company (Phillips). The merger between Conoco and Phillips (the merger) was consummated on August 30, 2002, at which time Conoco and Phillips combined their businesses by merging with separate acquisition subsidiaries of ConocoPhillips. As a result of the merger, Conoco and Phillips each became wholly owned subsidiaries of ConocoPhillips.


   Company Address: 925 N. Eldridge Parkway Houston 77079 TX
   Company Phone Number: 293-1000   Stock Exchange / Ticker: NYSE COP
   COP is expected to report next financial results on April 29, 2021. Next quarterly dividend pay out on June 01, 2021.


Customers Net Income grew by COP's customers Net margin grew to


6.75 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CVX        7.55% 
XOM        7.93% 
VLO        3.55% 
PSX        4.45% 
PBF   -100%    
MPC        1.89% 
• View Complete Report
   



Repare Therapeutics Inc

Sales and Earnings Unchanged

In the most recent fiscal period Repare Therapeutics Inc eps of $1.38 per share compared to $ a year ago and EPS turn positive from $-0.37 per share from the previous quarter.

Repare Therapeutics Inc reported operating income of $26.41 millions, in the most recent fiscal period, a deterioration from the operating shortfall of $C millions, realized in fourth quarter of 2019

Deerfield Healthcare Technology Acquisitions Corp

Sales and Earnings Unchanged

In the most recent fiscal period Deerfield Healthcare Technology Acquisitions Corp eps of $0.01 per share compared to $ a year ago and from $0.00 per share from the previous quarter.

Deerfield Healthcare Technology Acquisitions Corp reported operating income of $0.2412 millions, in the most recent fiscal period, a deterioration from the operating shortfall of $C millions, realized in fourth quarter of 2019
Deerfield Healthcare Technology Acquisitions Corp reported net loss of $-3.93 millions and Sales of $0.00 millions for the fiscal year 2020.

Company reported break-even compared to $0.00 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.

A M Castle and Co

A M Castle And Co announced fourth quarter of 2020 earnings season operating deficit of $-6.635 millions

In the fourth quarter of 2020 earnings season A M Castle And Co decreased loss of $-0.16 per share compared to $-4.50 a year ago and improved from $-0.20 per share from the previous quarter.

Sales faded by -38.58% to $77.40 millions from $126.02 millions in the same quarter a year ago and sequentially Sales decreased by -2.69% from $79.54 millions.
A M Castle And Co reported net loss of $-40.66 millions and Sales of $366.24 millions for the fiscal year 2020.

Company has decreased loss per share to $-7.27 from $-17.62 in the previous fiscal year, while Sales Tumbled by -34.55 % from $559.59 millions a year ago.

Dyne Therapeutics Inc

Turn into Profitability, Topline Crumbles

In the fourth quarter of 2020 earnings season Dyne Therapeutics Inc turn a round at $2.56 per share, compared to results of $-1.96 per share a year ago quarter, In the previous quarter company realized $-2.01 per share.

Electric Utilities company regained its profitability from the preceding quarter from $-2.01 per share, from $0.00 millions.
Dyne Therapeutics Inc reported net loss of $-59.44 millions and Sales of $0.00 millions for the fiscal year 2020.

Company recorded loss per share of $-4.13 compared to $0.36 in the previous fiscal year, while by 0 % from $6.65 billions a year ago.

Health Assurance Acquisition Corp

Health Assurance Acquisition Corp announced fourth quarter of 2020 operating surplus of $0.00099999999999989 millions

In the fourth quarter of 2020 Health Assurance Acquisition Corp reached break-even of $0.00 per share compared to $-1.96 a year ago and from $0.00 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $1.66 billions in the same quarter a year ago and sequentially from $0.00 millions.
Health Assurance Acquisition Corp reported net loss of $-3.39 millions and Sales of $0.00 millions for the fiscal year 2020.

Company reported break-even compared to $0.36 in the previous fiscal year, while by 0 % from $6.65 billions a year ago.






 

Conocophillips's Segments
 
Alaska
 Segment    14.61 % of total Revenue
Lower 48 Latin America
 Segment    42.53 % of total Revenue
Canada
 Segment    7.89 % of total Revenue
Europe
 Segment    20.27 % of total Revenue
Asia Pacific and Middle East
 Segment    14.71 % of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Conocophillips does not provide revenue guidance.

Earnings Outlook
Health Assurance Acquisition Corp does not provide earnings estimates.

 
Geographic Revenue Dispersion
United States 57.15 %
Norway 7.22 %
United Kingdom 12.55 %
Canada 8.39 %
Other 0.73 %
Australia 6.2 %
Malaysia 0.77 %
China 3.24 %
Indonesia 3.74 %

Conocophillips's Operating Statistics Decrease / Increase
       
• View Complete Report


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ORC's Profile

Stock Price

ORC's Financials

Business Description

Fundamentals

Charts & Quotes

ORC's News

Suppliers

ORC's Competitors

Customers & Markets

Economic Indicators

ORC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071